NCT06302738

Brief Summary

High blood pressure is the most common modifiable risk factor for cardiovascular diseases (CV). The large interindividual variability in clinical expression of the disease and response to treatment, however, makes the management of the hypertensive patient complex.Therefore, identifying phenotypes of hypertensive patients associated with a specific CV outcome or who tend to respond/not respond to treatment is of paramount importance for improving CV prevention. It has been shown that the phenotype of hypertensive patient with poor control of nighttime blood pressure values, especially when associated with a "non-dipper" profile, was associated with an increased risk of developing CV and cerebrovascular complications. The non-dipper profile and nocturnal hypertension are caused by several factors including excessive salt intake and dysautonomia. However, they are also inevitably influenced by sleep duration and the presence of sleep disorders: obstructive sleep apnea (OSA), but also insomnia and periodic movements of the lower limbs,such as those frequently seen in restless legs syndrome, are among the the main determinants related to altered nighttime pressure pattern. However, such disturbances are not systematically assessed during the performance of monitoring 24h pressor and their impact in the outcome of the hypertensive patient is unknown. The primary objective of this study is to phenotype non-dipper patients with or without nocturnal hypertension to determine the prevalence of sleep disorders such as sleep apnea syndrome, insomnia, and restless legs syndrome (RLS) (OSA diagnosed considering AHI\>5 events/hour, insomnia and RLS according to ICSD 3 criteria) and correlate the presence of various sleep disorders with cardiac organ damage, vascular, and renal damage mediated by hypertension.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
143

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Geographic Reach
1 country

11 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 16, 2024

Status Verified

April 1, 2024

Enrollment Period

1.7 years

First QC Date

March 4, 2024

Last Update Submit

April 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of sleep disorders

    Phenotype patients with non-dipper status with or without nocturnal hypertension in order to establish the prevalence of sleep disturbances such as sleep apnea syndrome, insomnia and restless legs syndrome

    baseline

Study Arms (1)

Non-dipper pattern at 24-hour BP monitoring

Defined as a nocturnal decrease systolic and/or in diastolic BP values \<10% compared to the corresponding daytime values;

Diagnostic Test: polysomnography

Interventions

polysomnographyDIAGNOSTIC_TEST

patients will undergo a home sleep study to evaluate the presence of sleep disorders

Non-dipper pattern at 24-hour BP monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with non-dipper status with or without nocturnal hypertension

You may qualify if:

  • \>18 years old;
  • arterial hypertension defined as: a) office systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg AND either 24-hour ambulatory systolic BP ≥130 mmHg and/or diastolic BP ≥80 mmHg OR b) the presence of antihypertensive treatment;
  • non-dipper pattern at 24-hour BP monitoring (confirmed on repeated ABPM including one performed within 3 months prior to enrolment and one after enrolment, both on the same antihypertensive treatment, if any), defined as a nocturnal decrease systolic and/or in diastolic BP values \<10% compared to the corresponding daytime values;
  • signed written informed consent;

You may not qualify if:

  • shift workers
  • atrial fibrillation/flutter;
  • pregnancy and lactation;
  • terminal malignant disease, life expectancy \<6 months;
  • limb amputation;
  • dementia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

UOSD Ipertensione Arteriosa "A.M. Pirrelli" - AUOC Policlinico di Bari, University of Bari,

Bari, Italy, Bari, 70120, Italy

RECRUITING

Azienda Sanitaria Locale della provincia di Brindisi

Brindisi, Italy, Brindisi, 72100, Italy

RECRUITING

Medicina Interna 1, Ambulatorio Ipertensione e Malattie Metaboliche AOU "Maggiore della carità"- Novara

Novara, Italy, Novara, 28100, Italy

RECRUITING

Padova 1- Clinica Medica 3 · Dipartimento di Medicina · Azienda Ospedaliera di Padova, Italy

Padua, Italy, Padova, 35128, Italy

RECRUITING

Padova 2 - UOC Medicina d'urgenza, Centro Regionale Specializzato per l'ipertensione arteriosa OSA - Azienda ospedaliera Università di Padova, Italy

Padua, Italy, Padova, 35128, Italy

RECRUITING

UO Cardiologia, UO Pneumologia, Presidio Ospedaliero Cittadella, Azienda ULSS 6 Euganea, Cittadella, Italy.

Cittadella, Italy, PD, 35013, Italy

NOT YET RECRUITING

Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia- S.O.S Centro per la Cura dell'Ipertensione Arteriosa- Medicina II Cardiovascolare

Reggio Emilia, Italy, RE, 42122, Italy

NOT YET RECRUITING

Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento- UO Medicina interna - Rovereto

Rovereto, Italy, Trento, 38068, Italy

NOT YET RECRUITING

Azienda sanitaria universitaria Giuliano-Isontina (ASU-GI)- SC (UCO) Medicina Clinica

Trieste, Italy, Trieste, 34128, Italy

NOT YET RECRUITING

Department of Medicine, University of Verona, Verona, Italy

Verona, Italy, Verona, 37126, Italy

RECRUITING

Istituto Auxologico Italiano IRCCS

Milan, MI, 20149, Italy

RECRUITING

MeSH Terms

Conditions

HypertensionSleep Wake Disorders

Interventions

Polysomnography

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Gianfranco Parati, MD

    Istituto Auxologico Italiano IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Martino Pengo, MD, PhD

CONTACT

Elisa Nardin, RN

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2024

First Posted

March 12, 2024

Study Start

May 4, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 16, 2024

Record last verified: 2024-04

Locations